Haemodialysis Vascular Grafts Market-Global Industry Analysis, Growth, Segmentation and Forecast-2023-2029

Haemodialysis Vascular Grafts Market is expected to grow at a CAGR of 4.1% during the forecast period. Global Haemodialysis Vascular Grafts Market is expected to reach US$ 325.89 Mn. by 2029. Haemodialysis vascular access dysfunctioning is a major reason for illness in the patients having haemodialysis and it also contributes notably towards total end-phase renal disorder expenses. Arteriovenous (AV) grafts refer to the type of access used in the process of haemodialysis and is usually placed in the arm. The blood-flow through the graft helps in a providing a systematic flow pattern and controlled flow rate that helps to deliver enough blood for an adequate haemodialysis treatment. Haemodialysis Vascular Grafts MarketTo know about the Research Methodology :- Request Free Sample Report According to WHO, the number of end stage renal disease patients globally, receiving dialysis will be approximately 5.24 Million by 2030. The cases associated with morbidity are mostly due to infection, haemorrhage and vascular grafts rejection by the human body. Due to the rejection reason of grafts by body, synthetic materials are being made with a blend of polymers to achieve the desired material strength, adhesion and durability. Bioengineered materials are expected to be the trendsetters in the forecast period, reason being the advantages such as negligible graft rejection and outstanding biocompatibility. Moreover, the increasing smoking cases are an important factor for driving the market demand. Increasing demand for minimally invasive surgeries, rising vascular disorders and diabetes are also augmenting the market growth. In addition, the rising geriatric population, cardiac arrest cases, diabetes and hypertension due to changing lifestyle are also responsible for rise in market revenue. Advancements in technology, funding for healthcare sector, increased activities in the R&D field also play a vital role. Emerging markets and increasing interest of stakeholders in investing here is expected to create new opportunities for haemodialysis vascular grafts market in the coming years. The report contains detailed analysis of Strengths, Weakness and opportunities of the key players operating in the Haemodialysis Vascular Grafts market. It also provides information on current market trends, competitive ranking analysis, regional bifurcation, turnover forecasts, industry drivers and the key challenges. The report has profiled ten key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques.

Haemodialysis Vascular Grafts Market Segment Analysis

By Raw materials, the Polytetrafluoroethylene segment is expected to lead the market with a revenue share of xx% in the forecast period. The Polytetrafluoroethylene segment held a prominent share of xx% in the year 2022 and is expected to continue the same. The reason being, it’s magnificent adhesion properties and fistula pliability. Characteristics such as high dielectric strength and low coefficient friction ensures smooth dialysis procedure in patients. Polyurethane holds second position in the market, owing to its material strength and a thinner inner wall as a vascular graft. Due to this, a larger diameter gets provided and ensures proper blood flow during the haemodialysis procedure. The Biological material segment is expected to be the fastest growing during the forecast period. Less infection rate, negligible graft rejection and low haemorrhage chances are the factors responsible for the segment growth. By end-use, the hospital segment is expected to register a CAGR of xx% during the forecast period. Hospitals held a leading revenue share of xx% in the Haemodialysis Vascular Grafts market in 2022. Surgeries and other operations are performed majorly in hospitals, due to availability of all tools and technologies required. Haemodialysis procedures conducted in hospitals or hospital-attached outpatient facilities enable ease of handling any emergency situations that may arise.

Haemodialysis Vascular Grafts Market Regional Insights

North America accounted for the largest share of Laparoscopic Ablation Devices Market in 2022 North America accounted for the largest share of xx% in 2022, reason being the rising prevalence of chronic kidney diseases. According to CDC, approximately 4.9 million people were diagnosed with kidney disease in US in 2017. Investments by key players in this field has boosted the market growth. The rising number of haemodialysis procedures in North America and the technological advancements in dialysis devices introduced by key market players in this region are rising the market growth. The high class infrastructure with all surgery facilities available is also propelling the market growth in this region. Asia Pacific is also expected to witness significant growth of xx% during the forecast period due to the increasing renal disorder cases. The allocation of a large amount of healthcare expenditure for hospitals and dispensing medicines to the elderly is expected drive the market demand.

Haemodialysis Vascular Grafts Market Scope:Inquire before Buying

Haemodialysis Vascular Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 245.98 Mn.
Forecast Period 2023 to 2029 CAGR: 4.1% Market Size in 2029: US $ 325.89 Mn.
Segments Covered: by Raw Materials Polyester Polytetrafluoroethylene Polyurethane Biological Materials
by End User Hospitals Ambulatory Care Centers Others

Haemodialysis Vascular Grafts Market By Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America

Haemodialysis Vascular Grafts Market Key Players

1. W.L. Gore & Associates 2. C.R. Bard, Inc 3. Terumo Medical Corporation 4. LeMaitre Vascular, INC 5. Gentinge AB 6. Vascular Genesis 7. InnA Vasc Medical, INC 8. CryoLife, INC 9. Merit Medical Systems, INC 10. Proteon Therapeutics, INC Frequently Asked Questions: 1] What segments are covered in Global Haemodialysis Vascular Grafts Market report? Ans. The segments covered in Burn Ointment Market report are based on Product, Depth of Burn, and End-Use. 2] Which region is expected to hold the highest share in the Global Haemodialysis Vascular Grafts Market? Ans. North America is expected to hold the highest share in the Burn Ointment Market. 3] Which segment holds the largest market share in the Global Haemodialysis Vascular Grafts Market by 2029? Ans. Topical Antibiotics segment hold the largest market share in the Burn Ointment market by 2029. 4] What is the market size of the Global Haemodialysis Vascular Grafts Market by 2029? Ans. The market size of the Burn Ointment market is expected to reach US $325.89 Mn. by 2029. 5] What was the market size of the Global Haemodialysis Vascular Grafts Market in 2022? Ans. The market size of the Burn Ointment market was worth US $245.98 Mn. in 2022.
Global Haemodialysis Vascular Grafts Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: HAEMODIALYSIS VASCULAR GRAFTS Market Size, By Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global HAEMODIALYSIS VASCULAR GRAFTS Market Analysis and Forecast 6.1. HAEMODIALYSIS VASCULAR GRAFTS Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global HAEMODIALYSIS VASCULAR GRAFTS Market Analysis and Forecast, By Raw materials 7.1. Introduction and Definition 7.2. Key Findings 7.3. HAEMODIALYSIS VASCULAR GRAFTS Market Value Share Analysis, By Raw materials 7.4. HAEMODIALYSIS VASCULAR GRAFTS Market Size (US$ Mn) Forecast, By Raw materials 7.5. HAEMODIALYSIS VASCULAR GRAFTS Market Analysis, By Raw materials 7.6. HAEMODIALYSIS VASCULAR GRAFTS Market Attractiveness Analysis, By Raw materials 8. Global HAEMODIALYSIS VASCULAR GRAFTS Market Analysis and Forecast, By End-users 8.1. Introduction and Definition 8.2. Key Findings 8.3. HAEMODIALYSIS VASCULAR GRAFTS Market Value Share Analysis, By End-users 8.4. HAEMODIALYSIS VASCULAR GRAFTS Market Size (US$ Mn) Forecast, By End-users 8.5. HAEMODIALYSIS VASCULAR GRAFTS Market Analysis, By End-users 8.6. HAEMODIALYSIS VASCULAR GRAFTS Market Attractiveness Analysis, By End-users 9. Global HAEMODIALYSIS VASCULAR GRAFTS Market Analysis, By Region 9.1. HAEMODIALYSIS VASCULAR GRAFTS Market Value Share Analysis, By Region 9.2. HAEMODIALYSIS VASCULAR GRAFTS Market Size (US$ Mn) Forecast, By Region 9.3. HAEMODIALYSIS VASCULAR GRAFTS Market Attractiveness Analysis, By Region 10. North America HAEMODIALYSIS VASCULAR GRAFTS Market Analysis 10.1. Key Findings 10.2. North America HAEMODIALYSIS VASCULAR GRAFTS Market Overview 10.3. North America HAEMODIALYSIS VASCULAR GRAFTS Market Value Share Analysis, By Raw materials 10.4. North America HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 10.4.1. Polyester 10.4.2. Polytetrafluoroethylene 10.4.3. Polyurethane 10.4.4. Biological Materials 10.5. North America HAEMODIALYSIS VASCULAR GRAFTS Market Value Share Analysis, By End-users 10.6. North America HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 10.6.1. Hospitals 10.6.2. Ambulatory Care Centers 10.6.3. Others 10.7. North America HAEMODIALYSIS VASCULAR GRAFTS Market Value Share Analysis, By Country 10.8. North America HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Country 10.8.1. U.S. 10.8.2. Canada 10.8.3. Mexico 10.9. North America HAEMODIALYSIS VASCULAR GRAFTS Market Analysis, By Country 10.10. U.S. HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 10.10.1. Polyester 10.10.2. Polytetrafluoroethylene 10.10.3. Polyurethane 10.10.4. Biological Materials 10.11. U.S. HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 10.11.1. Hospitals 10.11.2. Ambulatory Care Centers 10.11.3. Others 10.12. Canada HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 10.12.1. Polyester 10.12.2. Polytetrafluoroethylene 10.12.3. Polyurethane 10.12.4. Biological Materials 10.13. Canada HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 10.13.1. Hospitals 10.13.2. Ambulatory Care Centers 10.13.3. Others 10.14. Mexico HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 10.14.1. Polyester 10.14.2. Polytetrafluoroethylene 10.14.3. Polyurethane 10.14.4. Biological Materials 10.15. Mexico HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 10.15.1. Hospitals 10.15.2. Ambulatory Care Centers 10.15.3. Others 10.16. North America HAEMODIALYSIS VASCULAR GRAFTS Market Attractiveness Analysis 10.16.1. By Raw materials 10.16.2. By End-users 10.17. PEST Analysis 10.18. Key Trends 10.19. Key Developments 11. Europe HAEMODIALYSIS VASCULAR GRAFTS Market Analysis 11.1. Key Findings 11.2. Europe HAEMODIALYSIS VASCULAR GRAFTS Market Overview 11.3. Europe HAEMODIALYSIS VASCULAR GRAFTS Market Value Share Analysis, By Raw materials 11.4. Europe HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 11.4.1. Polyester 11.4.2. Polytetrafluoroethylene 11.4.3. Polyurethane 11.4.4. Biological Materials 11.5. Europe HAEMODIALYSIS VASCULAR GRAFTS Market Value Share Analysis, By End-users 11.6. Europe HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 11.6.1. Hospitals 11.6.2. Ambulatory Care Centers 11.6.3. Others 11.7. Europe HAEMODIALYSIS VASCULAR GRAFTS Market Value Share Analysis, By Country 11.8. Europe HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Sweden 11.8.7. CIS countries 11.8.8. Rest of Europe 11.9. Germany HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 11.9.1. Polyester 11.9.2. Polytetrafluoroethylene 11.9.3. Polyurethane 11.9.4. Biological Materials 11.10. Germany HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 11.10.1. Hospitals 11.10.2. Ambulatory Care Centers 11.10.3. Others 11.11. U.K. HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 11.11.1. Polyester 11.11.2. Polytetrafluoroethylene 11.11.3. Polyurethane 11.11.4. Biological Materials 11.12. U.K. HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 11.12.1. Hospitals 11.12.2. Ambulatory Care Centers 11.12.3. Others 11.13. France HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 11.13.1. Polyester 11.13.2. Polytetrafluoroethylene 11.13.3. Polyurethane 11.13.4. Biological Materials 11.14. France HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 11.14.1. Hospitals 11.14.2. Ambulatory Care Centers 11.14.3. Others 11.15. Italy HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 11.15.1. Polyester 11.15.2. Polytetrafluoroethylene 11.15.3. Polyurethane 11.15.4. Biological Materials 11.16. Italy HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 11.16.1. Hospitals 11.16.2. Ambulatory Care Centers 11.16.3. Others 11.17. Spain HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 11.17.1. Polyester 11.17.2. Polytetrafluoroethylene 11.17.3. Polyurethane 11.17.4. Biological Materials 11.18. Spain HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 11.18.1. Hospitals 11.18.2. Ambulatory Care Centers 11.18.3. Others 11.19. Sweden HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 11.19.1. Polyester 11.19.2. Polytetrafluoroethylene 11.19.3. Polyurethane 11.19.4. Biological Materials 11.20. Sweden HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 11.20.1. Hospitals 11.20.2. Ambulatory Care Centers 11.20.3. Others 11.21. CIS countries HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 11.21.1. Polyester 11.21.2. Polytetrafluoroethylene 11.21.3. Polyurethane 11.21.4. Biological Materials 11.22. CIS countries HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 11.22.1. Hospitals 11.22.2. Ambulatory Care Centers 11.22.3. Others 11.23. Rest of Europe HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 11.23.1. Polyester 11.23.2. Polytetrafluoroethylene 11.23.3. Polyurethane 11.23.4. Biological Materials 11.24. Rest of Europe HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 11.24.1. Hospitals 11.24.2. Ambulatory Care Centers 11.24.3. Others 11.25. Europe HAEMODIALYSIS VASCULAR GRAFTS Market Attractiveness Analysis 11.25.1. By End-users 11.25.2. By Raw materials 11.26. PEST Analysis 11.27. Key Trends 11.28. Key Developments 12. Asia Pacific HAEMODIALYSIS VASCULAR GRAFTS Market Analysis 12.1. Key Findings 12.2. Asia Pacific HAEMODIALYSIS VASCULAR GRAFTS Market Overview 12.3. Asia Pacific HAEMODIALYSIS VASCULAR GRAFTS Market Value Share Analysis, By Raw materials 12.4. Asia Pacific HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 12.4.1. Polyester 12.4.2. Polytetrafluoroethylene 12.4.3. Polyurethane 12.4.4. Biological Materials 12.5. Asia Pacific HAEMODIALYSIS VASCULAR GRAFTS Market Value Share Analysis, By End-users 12.6. Asia Pacific HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 12.6.1. Hospitals 12.6.2. Ambulatory Care Centers 12.6.3. Others 12.7. Asia Pacific HAEMODIALYSIS VASCULAR GRAFTS Market Value Share Analysis, By Country 12.8. Asia Pacific HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. South Korea 12.8.5. Australia 12.8.6. ASEAN 12.8.7. Rest of Asia Pacific 12.9. Asia Pacific HAEMODIALYSIS VASCULAR GRAFTS Market Analysis, By Country 12.10. China HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 12.10.1. Polyester 12.10.2. Polytetrafluoroethylene 12.10.3. Polyurethane 12.10.4. Biological Materials 12.11. China HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 12.11.1. Hospitals 12.11.2. Ambulatory Care Centers 12.11.3. Others 12.12. India HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 12.12.1. Polyester 12.12.2. Polytetrafluoroethylene 12.12.3. Polyurethane 12.12.4. Biological Materials 12.13. India HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 12.13.1. Hospitals 12.13.2. Ambulatory Care Centers 12.13.3. Others 12.14. Japan HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 12.14.1. Polyester 12.14.2. Polytetrafluoroethylene 12.14.3. Polyurethane 12.14.4. Biological Materials 12.15. Japan HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 12.15.1. Hospitals 12.15.2. Ambulatory Care Centers 12.15.3. Others 12.16. South Korea HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 12.16.1. Polyester 12.16.2. Polytetrafluoroethylene 12.16.3. Polyurethane 12.16.4. Biological Materials 12.17. South Korea HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 12.17.1. Hospitals 12.17.2. Ambulatory Care Centers 12.17.3. Others 12.18. Australia HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 12.18.1. Polyester 12.18.2. Polytetrafluoroethylene 12.18.3. Polyurethane 12.18.4. Biological Materials 12.19. Australia HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 12.19.1. Hospitals 12.19.2. Ambulatory Care Centers 12.19.3. Others 12.20. ASEAN HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 12.20.1. Polyester 12.20.2. Polytetrafluoroethylene 12.20.3. Polyurethane 12.20.4. Biological Materials 12.21. ASEAN HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 12.21.1. Hospitals 12.21.2. Ambulatory Care Centers 12.21.3. Others 12.22. Rest of Asia Pacific HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 12.22.1. Polyester 12.22.2. Polytetrafluoroethylene 12.22.3. Polyurethane 12.22.4. Biological Materials 12.23. Rest of Asia Pacific HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 12.23.1. Hospitals 12.23.2. Ambulatory Care Centers 12.23.3. Others 12.24. Asia Pacific HAEMODIALYSIS VASCULAR GRAFTS Market Attractiveness Analysis 12.24.1. By Raw materials 12.24.2. By End-users 12.25. PEST Analysis 12.26. Key Trends 12.27. Key Developments 13. Middle East & Africa HAEMODIALYSIS VASCULAR GRAFTS Market Analysis 13.1. Key Findings 13.2. Middle East & Africa HAEMODIALYSIS VASCULAR GRAFTS Market Overview 13.3. Middle East & Africa HAEMODIALYSIS VASCULAR GRAFTS Market Value Share Analysis, By Raw materials 13.4. Middle East & Africa HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 13.4.1. Polyester 13.4.2. Polytetrafluoroethylene 13.4.3. Polyurethane 13.4.4. Biological Materials 13.5. Middle East & Africa HAEMODIALYSIS VASCULAR GRAFTS Market Value Share Analysis, By End-users 13.6. Middle East & Africa HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 13.6.1. Hospitals 13.6.2. Ambulatory Care Centers 13.6.3. Others 13.7. Middle East & Africa HAEMODIALYSIS VASCULAR GRAFTS Market Value Share Analysis, By Country 13.8. Middle East & Africa HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Country 13.8.1. GCC Countries 13.8.2. South Africa 13.8.3. Nigeria 13.8.4. Egypt 13.8.5. Rest of Middle East & Africa 13.9. Middle East & Africa HAEMODIALYSIS VASCULAR GRAFTS Market Analysis, By Country 13.10. GCC Countries HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 13.10.1. Polyester 13.10.2. Polytetrafluoroethylene 13.10.3. Polyurethane 13.10.4. Biological Materials 13.11. GCC Countries HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 13.11.1. Hospitals 13.11.2. Ambulatory Care Centers 13.11.3. Others 13.12. South Africa HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 13.12.1. Polyester 13.12.2. Polytetrafluoroethylene 13.12.3. Polyurethane 13.12.4. Biological Materials 13.13. South Africa HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 13.13.1. Hospitals 13.13.2. Ambulatory Care Centers 13.13.3. Others 13.14. Nigeria HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 13.14.1. Polyester 13.14.2. Polytetrafluoroethylene 13.14.3. Polyurethane 13.14.4. Biological Materials 13.15. Nigeria HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 13.15.1. Hospitals 13.15.2. Ambulatory Care Centers 13.15.3. Others 13.16. Egypt HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 13.16.1. Polyester 13.16.2. Polytetrafluoroethylene 13.16.3. Polyurethane 13.16.4. Biological Materials 13.17. Egypt HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 13.17.1. Hospitals 13.17.2. Ambulatory Care Centers 13.17.3. Others 13.18. Rest of Middle East & Africa HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 13.18.1. Polyester 13.18.2. Polytetrafluoroethylene 13.18.3. Polyurethane 13.18.4. Biological Materials 13.19. Rest of Middle East & Africa HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 13.19.1. Hospitals 13.19.2. Ambulatory Care Centers 13.19.3. Others 13.20. Middle East & Africa HAEMODIALYSIS VASCULAR GRAFTS Market Attractiveness Analysis 13.20.1. By Raw materials 13.20.2. By End-users 13.21. PEST Analysis 13.22. Key Trends 13.23. Key Developments 14. South America HAEMODIALYSIS VASCULAR GRAFTS Market Analysis 14.1. Key Findings 14.2. South America HAEMODIALYSIS VASCULAR GRAFTS Market Overview 14.3. South America HAEMODIALYSIS VASCULAR GRAFTS Market Value Share Analysis, By Raw materials 14.4. South America HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 14.4.1. Polyester 14.4.2. Polytetrafluoroethylene 14.4.3. Polyurethane 14.4.4. Biological Materials 14.5. South America HAEMODIALYSIS VASCULAR GRAFTS Market Value Share Analysis, By End-users 14.6. South America HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 14.6.1. Hospitals 14.6.2. Ambulatory Care Centers 14.6.3. Others 14.7. South America HAEMODIALYSIS VASCULAR GRAFTS Market Value Share Analysis, By Country 14.8. South America HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Country 14.8.1. Brazil 14.8.2. Colombia 14.8.3. Argentina 14.8.4. Rest of South America 14.9. South America HAEMODIALYSIS VASCULAR GRAFTS Market Analysis, By Country 14.10. Brazil HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 14.10.1. Polyester 14.10.2. Polytetrafluoroethylene 14.10.3. Polyurethane 14.10.4. Biological Materials 14.11. Brazil HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 14.11.1. Hospitals 14.11.2. Ambulatory Care Centers 14.11.3. Others 14.12. Colombia HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 14.12.1. Polyester 14.12.2. Polytetrafluoroethylene 14.12.3. Polyurethane 14.12.4. Biological Materials 14.13. Colombia HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 14.13.1. Hospitals 14.13.2. Ambulatory Care Centers 14.13.3. Others 14.14. Argentina HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 14.14.1. Polyester 14.14.2. Polytetrafluoroethylene 14.14.3. Polyurethane 14.14.4. Biological Materials 14.15. Argentina HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 14.15.1. Hospitals 14.15.2. Ambulatory Care Centers 14.15.3. Others 14.16. Rest of South America HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By Raw materials 14.16.1. Polyester 14.16.2. Polytetrafluoroethylene 14.16.3. Polyurethane 14.16.4. Biological Materials 14.17. Rest of South America HAEMODIALYSIS VASCULAR GRAFTS Market Forecast, By End-users 14.17.1. Hospitals 14.17.2. Ambulatory Care Centers 14.17.3. Others 14.18. South America HAEMODIALYSIS VASCULAR GRAFTS Market Attractiveness Analysis 14.18.1. By Raw materials 14.18.2. By End-users 14.19. PEST Analysis 14.20. Key Trends 14.21. Key Developments 15. Company Profiles 15.1. Market Share Analysis, By Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players By price, presence, market share, End-users, and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A By Regions, Investment and End-users 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. W.L. Gore & Associates 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. C.R. Bard, Inc 15.3.3. Terumo Medical Corporation 15.3.4. LeMaitre Vascular, INC 15.3.5. Gentinge AB 15.3.6. Vascular Genesis 15.3.7. InnA Vasc Medical, INC 15.3.8. CryoLife, INC 15.3.9. Merit Medical Systems, INC 15.3.10. Proteon Therapeutics, INC 15.3.11. Others
  • INQUIRE BEFORE BUYING